Safety Pharmacology Society logo

  • Contact Us
  • 703.547.0874
    • Facebook
    • Twitter
    • Linkedin
  • About
    • What is SP?
    • Mission
    • Board
    • Committees
    • History
    • Support SPS
    • Advertising Opportunities
  • Meetings
    • Annual Meetings
    • Regional Meetings
    • Exhibitor Opportunities
    • Sponsorship Opportunities
    • Award Opportunities
    • Meeting Calendar
  • Education
    • Webinars
    • Diplomate in Safety Pharmacology
    • Other Education Opportunities
  • Resources
    • JPTM
    • SPeak Blog
    • SPotlight Newsletter
    • Students
    • Regulatory Guidance
    • Animals Use in Research
    • Job Bank
    • Sites of Interest
    • Publications
    • Vendor Directory
    • Tutorials
  • Members
    • SPShare
    • Become a Member
    • Membership Renewal
    • Update Member Record
    • Member Directory
  • Sign In
    • Sign In
      (Lost Password?)
      Create Account
      (Lost Password?)

      Already have an account? Log In!

      Reset My Password

      Complete the form below to receive an email with the authorization code needed to reset your password.

      (Lost Password?)

      Already have an account? Log In!

  • 2020 Virtual Meeting
  • Earn the Top Credentials in the Field of Safety Pharmacology
    Diplomate in Safety Pharmacology (DSP)
    Register Today!
  • Become a Member
    Join us in our vision to lead the global safety pharmacology community in the development
    and safe medical use of biologically active molecular entities by bridging across disciplines to predict,
    identify, characterize, and monitor potentially undesirable pharmacodynamic activities in
    nonclinical studies and guiding their translation into clinical trials and beyond, to benefit all patients.

SPShare

Meetings

Diplomate

Journal

Donate

SPS News

16 December

ICH E14 and S7B: A Note From the SPS President

Dear Members of SPS, Since the link between serious ventricular arrhythmias among patients taking e... read more

25 November

ICH E14/S7B Q&As: Public Comment Closes Soon!

As a safety pharmacology leader, your voice matters! The ICH E14/S7B Q&As are still open for co... read more

3 November

Webinar of Interest! An Update on COVID-19: Basic and Clinical Perspectives

... read more

Scientific News

19 January

COVID-19 has multiple faces

According to current studies, the COVID-19 disease which is caused by the SARS-CoV-2 coronavirus com... read more

19 January

Comunicado de la FDA sobre la seguridad de los medicamentos: FDA advierte que el medicamento antipirético y analgésico acetaminofén (paracetamol) puede causar reacciones poco comunes pero serias en la piel

El primero de agosto, 2013, La Administración de Alimentos y Medicamentos (FDA por sus siglas en ing... read more

19 January

FDA updates on hand sanitizers consumers should not use

FDA Warns consumers and healthcare professionals of Hand Sanitizers contaminated with Methanol... read more

19 January

Hand Sanitizers | COVID-19

Help meet the increased demand for safe and effective hand sanitizers during the COVID-19 public hea... read more

19 January

Comunicado de la FDA sobre la seguridad de los medicamentos: FDA advierte que el medicamento para el cáncer docetaxel puede causar síntomas de intoxicación alcohólica después del tratamiento

[6-20-2014] La Administración de Alimentos y Medicamentos de Estados Unidos (FDA por sigla en inglés... read more

19 January

Comunicado de la FDA sobre la seguridad de los medicamentos: FDA advierte sobre el riesgo de menor nivel de alerta mental la mañana posterior al uso del medicamento Lunesta contra el insomnio (eszopiclona) y recomienda disminuir la dosis

[16 de mayo del 2014] La Administración de Alimentos y Medicamentos de Estados Unidos (FDA por su si... read more

Get in Touch

Sign up to receive emails

Create a new account with SPS to opt in to receive emails from headquarters about Meetings, News, and additional resources.

Success! You've been added to our email list.

Contact Us

  • Address: 11190 Sunrise Valley Drive, Suite 300, Reston, VA, United States

  • Tel: 703.547.0874

  • Email: SPS Headquarters

Follow Us

  • Facebook
  • Twitter
  • Linkedin
Logo SPS

© Copyright 2021. All Rights Reserved.

  • Sitemap
  • Privacy Policy and Disclaimers